Study of Noni in Cancer Patients

Completed · Phase 1

Conditions studied: Neoplasms, Neoplasm Metastasis

In brief

The purpose of this Phase 1 study is to: 1. determine the maximum tolerated dose of capsules containing 500mg of freeze dried noni fruit extract, 2. define toxicities associated with the ingestion of noni, 3. collect preliminary information on the efficacy of noni in respect to anti-tumor and symptom control properties to help select specific patients for subsequent Phase 2 studies, 4. identify chemical constituents of the extract that can be used to characterize the bioavailability and pharmacokinetics of noni food supplement.

Key facts

Study ID

NCT00033878

Run by

National Center for Complementary and Integrative Health (NCCIH)

Starts

2001-11-01

Expected to finish

2006-06-01

Last updated by the study team

2007-03-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Hawaii, Cancer Research Center — Honolulu, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.